PortfoliosLab logoPortfoliosLab logo
ARKG vs. DBE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ARKG vs. DBE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and Invesco DB Energy Fund (DBE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARKG achieves a 17.09% return, which is significantly lower than DBE's 83.68% return. Over the past 10 years, ARKG has underperformed DBE with an annualized return of 7.22%, while DBE has yielded a comparatively higher 12.03% annualized return.


ARKG

1D
-0.24%
1M
10.92%
YTD
17.09%
6M
10.02%
1Y
53.35%
3Y*
0.67%
5Y*
-15.72%
10Y*
7.22%

DBE

1D
2.33%
1M
-5.45%
YTD
83.68%
6M
74.95%
1Y
84.41%
3Y*
23.42%
5Y*
19.66%
10Y*
12.03%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. DBE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
17.09%23.04%-28.24%16.22%-53.90%-33.92%180.40%44.00%-1.26%46.61%
DBE
Invesco DB Energy Fund
83.68%-2.17%2.96%-12.14%33.77%57.56%-25.91%19.72%-12.95%5.21%

Correlation

The correlation between ARKG and DBE is -0.26, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.26

Correlation (3Y)
Calculated over the trailing 3-year period

-0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Nov 3, 2014

0.08

The correlation between ARKG and DBE shifts across timeframes, from -0.26 (1 year) to 0.09 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARKG vs. DBE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG
ARKG Risk / Return Rank: 3535
Overall Rank
ARKG Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
ARKG Sortino Ratio Rank: 3737
Sortino Ratio Rank
ARKG Omega Ratio Rank: 3232
Omega Ratio Rank
ARKG Calmar Ratio Rank: 3838
Calmar Ratio Rank
ARKG Martin Ratio Rank: 3131
Martin Ratio Rank

DBE
DBE Risk / Return Rank: 7171
Overall Rank
DBE Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
DBE Sortino Ratio Rank: 6363
Sortino Ratio Rank
DBE Omega Ratio Rank: 6565
Omega Ratio Rank
DBE Calmar Ratio Rank: 9191
Calmar Ratio Rank
DBE Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. DBE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and Invesco DB Energy Fund (DBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARKGDBEDifference
Sharpe ratioReturn per unit of total volatility

-1.12

Sortino ratioReturn per unit of downside risk

-0.97

Omega ratioGain probability vs. loss probability

1.22

1.40

-0.18

Calmar ratioReturn relative to maximum drawdown

1.95

5.89

-3.94

Martin ratioReturn relative to average drawdown

4.67

11.53

-6.86

ARKG vs. DBE - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.31, which is lower than the DBE Sharpe Ratio of 2.43. The chart below compares the historical Sharpe Ratios of ARKG and DBE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ARKGDBEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.31

2.43

-1.12

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.35

0.67

-1.02

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

0.43

-0.25

Sharpe Ratio (All Time)

Calculated using the full available price history

0.13

0.09

+0.04

Drawdowns

ARKG vs. DBE - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, roughly equal to the maximum DBE drawdown of -86.69%. Use the drawdown chart below to compare losses from any high point for ARKG and DBE.


Loading charts...

Drawdown Indicators


ARKGDBEDifference

Max Drawdown

Largest peak-to-trough decline

-83.59%

-86.69%

+3.10%

Max Drawdown (1Y)

Largest decline over 1 year

-27.51%

-14.41%

-13.10%

Max Drawdown (3Y)

Largest decline over 3 years

-51.96%

-23.89%

-28.07%

Max Drawdown (5Y)

Largest decline over 5 years

-80.18%

-38.74%

-41.44%

Max Drawdown (10Y)

Largest decline over 10 years

-83.59%

-60.84%

-22.75%

Current Drawdown

Current decline from peak

-69.65%

-30.27%

-39.38%

Average Drawdown

Average peak-to-trough decline

-35.87%

-57.31%

+21.44%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.46%

7.35%

+4.11%

Volatility

ARKG vs. DBE - Volatility Comparison

The current volatility for ARK Genomic Revolution Multi-Sector ETF (ARKG) is 11.90%, while Invesco DB Energy Fund (DBE) has a volatility of 12.95%. This indicates that ARKG experiences smaller price fluctuations and is considered to be less risky than DBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARKGDBEDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.90%

12.95%

-1.05%

Volatility (6M)

Calculated over the trailing 6-month period

28.77%

30.86%

-2.09%

Volatility (1Y)

Calculated over the trailing 1-year period

41.12%

34.97%

+6.15%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.61%

29.39%

+16.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.12%

28.33%

+12.79%

ARKG vs. DBE - Expense Ratio Comparison

ARKG has a 0.75% expense ratio, which is lower than DBE's 0.78% expense ratio.


Dividends

ARKG vs. DBE - Dividend Comparison

ARKG has not paid dividends to shareholders, while DBE's dividend yield for the trailing twelve months is around 2.10%.


PositionTTM202520242023202220212020201920182017
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.00%0.62%0.85%3.14%0.82%1.34%
DBE
Invesco DB Energy Fund
2.10%3.86%6.32%3.87%0.75%0.00%0.00%1.79%1.67%0.00%

Frequently Asked Questions


ARKG and DBE have a correlation of -0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DBE has higher volatility (12.95%) compared to ARKG (11.90%). In terms of maximum drawdown, ARKG dropped -83.59% vs DBE's -86.69%.

On 10-year performance, DBE leads with 12.03% vs 7.22% for ARKG. On fees, ARKG is cheaper at 0.75% per year. On volatility, ARKG has been the lower-risk option at 11.90%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, DBE has performed better with a 12.03% return vs 7.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

ARKG is cheaper with a 0.75% expense ratio, compared with 0.78% for DBE.

DBE has the higher dividend yield at 2.10%, compared with 0.00% for ARKG.

ARKG is categorized as Health & Biotech Equities, while DBE is Oil & Gas. They also come from different issuers: ARK and Invesco. Their fees differ too: 0.75% for ARKG and 0.78% for DBE.

DBE currently has the higher Sharpe Ratio (2.43 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARKG and DBE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer